

Four months for validation? Try 45 minutes instead.
In the highly regulated life sciences industry, software validation remains one of the most significant hurdles to implementing new technologies. Manufacturing execution systems (MES), which are essential for modernizing production processes, often face lengthy implementation delays due to regulators' validation requirements. The good news? Savvy companies are now slashing validation times by up to 80% through innovative approaches and tools designed specifically for cloud-based environments.
For regulated companies who implement a manufacturing execution system, validation can consume enormous resources. Traditional approaches often require extensive documentation, repetitive testing, and lengthy approval cycles. It's not uncommon for validation activities to stretch across four months or longer for the implementation of a single computer system.
The challenge becomes even more daunting in some cloud environments. While on-premises software might require validation every few years, cloud-based manufacturing execution software typically releases updates quarterly. Without an optimized validation strategy, production and quality teams can find themselves in a perpetual validation cycle that diverts valuable resources from other critical activities.
The U.S. Food and Drug Administration (FDA) has long advocated for a risk-based approach to validation, as outlined in their "Pharmaceutical cGMPs for the 21st Century" initiative.1 This philosophy encourages companies to focus validation efforts on aspects that present the highest risk to product quality and patient safety.
Building on this foundation, MasterControl has developed a streamlined methodology for manufacturing execution system validation that can dramatically reduce the time and resources required to validate an MES while maintaining compliance with regulatory requirements.
Based on over two decades of experience working with regulated companies, these validation best practices can transform how life sciences organizations approach MES validation:
Software providers, particularly those offering software-as-a-service (SaaS) solutions, typically produce extensive validation documentation as an integral part of testing their products. Both the FDA and industry guidance (like GAMP 5) recommend leveraging this supplier documentation rather than recreating everything from scratch.
The GAMP 5 guidance notes that regulated companies should seek to maximize supplier involvement throughout the system life cycle in order to leverage knowledge, experience, and documentation, subject to satisfactory supplier assessment.2
Leading manufacturing execution software providers perform comprehensive functional testing before each release. By incorporating this testing into your validation package, you can avoid duplicating efforts while ensuring system quality.
While customization offers flexibility, it significantly increases validation complexity. Adopting the best practice configurations recommended by an MES provider with a proven track record of validation excellence can drastically reduce implementation time and simplify future validation efforts.
Not all aspects of a manufacturing execution system carry equal risk. A thorough risk assessment based on your specific configuration and usage patterns allows you to focus validation efforts where they matter most.
Instead of validating every possible function, concentrate on the critical business processes that directly impact product quality and regulatory compliance. This targeted approach ensures comprehensive coverage of high-risk areas while eliminating unnecessary testing.
Ready to transform your software validation process? Download the complete guide to compliant and quick software validation for in-depth strategies.
Many organizations claim to follow risk-based validation while still treating every system aspect as high-risk. Authentic risk-based validation requires identifying genuinely critical areas and focusing resources accordingly.
As the FDA guidance on software validation states: "The selection of validation activities, tasks, and work items should be commensurate with the complexity of the software design and the risk associated with the use of the software for the specified intended use."3
Instead of performing complete revalidation for minor upgrades, implement a change control methodology that allows for targeted validation of modified features. This approach reduces documentation overhead and streamlines the approval process.
While counterintuitive, frequent upgrades with smaller validation efforts are more efficient than infrequent, massive validation projects. Regular updates keep systems current with the latest features and security enhancements while maintaining a manageable validation workload.
With the recognition of the FDA, MasterControl developed the Validation Excellence Tool (VxT), a patented solution that quantifies and streamlines risk-based validation. This revolutionary tool:
For manufacturing execution system implementations, VxT has demonstrated remarkable results. What once required months of effort can now be completed in days or even hours. For system upgrades, the validation time has been reduced to as little as 45 minutes in some cases – an efficiency improvement that transforms how life sciences companies approach their manufacturing technology strategy.
The implications for life sciences manufacturing are profound. Companies adopting these validation best practices report:
If your organization is struggling with lengthy, resource-consuming MES validation processes, consider these steps:
Want to see how leading companies are validating their systems in record time? Download our comprehensive industry brief for detailed implementation strategies.
The life sciences industry is moving toward even more streamlined approaches in the digital era, including self-validating software that can validate at the click of a button. These innovations will further reduce the burden of validation without jeopardizing regulatory compliance.
As manufacturing becomes increasingly digitized, efficient validation processes will be a key competitive advantage for life sciences companies. Organizations that master these approaches will be better positioned to implement advanced manufacturing execution systems that drive quality improvements, cost reductions, and accelerated time to market.
Software validation doesn't need to be the bottleneck that delays implementation of your manufacturing execution system. By adopting a risk-based approach, leveraging supplier documentation, focusing on critical business processes, and utilizing modern tools like the Validation Excellence Tool, life sciences companies can dramatically reduce validation times while maintaining compliance with regulatory requirements.
In today's ultra-competitive market, the ability to quickly deploy and update manufacturing execution software can provide a significant competitive advantage. Companies that master efficient validation processes will be better positioned to leverage technology for operational excellence and accelerated product delivery.
Ready to transform your validation approach? Download our industry brief on compliant and quick software validation to learn how leading companies are validating their systems in record time.
As the life sciences industry continues to evolve, those who embrace modern validation methodologies will lead the way in bringing life-changing products to market faster and more efficiently than ever before.
References: